Skip to main content
. 2022 Feb 25;12:3225. doi: 10.1038/s41598-022-07334-w

Figure 7.

Figure 7

Correlations between risk model and immune checkpoints in bladder cancer. Comparing the expressions of (A) CTLA4; (B) LAG3; (C) PDL1; (D) PD1; (E) TIGIT; (F) GAL9; (G) TIM-3 and (H) PD1LG2 in high and low bladder cancer subjects. Ns: not significant; *p < 0.05; ***p < 0.001.